Checking whether BNP predicts outcomes in advanced heart failure
Part of Heart & circulation clinical trials.
This study looks at whether a blood test called BNP can help predict what happens over time in people being evaluated for advanced heart failure treatment. It may help doctors better plan care and follow-up for patients long-term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been referred to be evaluated for advanced treatment for heart failure at Rigshospitalet in Denmark.
- You are able and willing to give informed consent to join the study.
- You will need to complete whatever study follow-up procedures they require for the long-term tracking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a simple blood test (NT-proBNP) to find heart failure early in people who have symptoms but haven't been diagnosed yet. If the test levels are high, it could help doctors start treatment sooner.
This study looks at certain proteins in your blood to help doctors better understand and diagnose a type of heart failure called HFpEF. You might be able to join if your doctor recently ordered a blood test for NT-proBNP because they thought you might have heart failure.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This study checks whether using a specific blood test (called sST-2) to guide heart-failure treatment leads to better care and outcomes. It may help by tailoring treatment decisions based on your test results.
This study checks whether short-term follow-up blood test results after you leave the hospital can predict how you do with heart failure. It may help doctors choose better follow-up and treatment plans based on your early test trends.
This study looks at hospital and emergency patients with heart failure and uses “omics” (advanced lab data from the body) plus statistics and artificial intelligence to predict who is likely to return to the hospital soon. If it works, it could help doctors better plan follow-up care to reduce repeat hospital visits.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.